cholestane-3,5,6-triol has been researched along with Cerebral Cholesterinosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arias, A; Coll, MJ; de las Heras, J; García-Villoria, J; Girós, M; Macías-Vidal, J; Pajares, S; Ribes, A; Ros, E | 1 |
1 other study(ies) available for cholestane-3,5,6-triol and Cerebral Cholesterinosis
Article | Year |
---|---|
Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Child, Preschool; Cholestanols; Female; Humans; Infant; Infant, Newborn; Ketocholesterols; Male; Middle Aged; Niemann-Pick Disease, Type C; Spectrometry, Mass, Electrospray Ionization; Wolman Disease; Xanthomatosis, Cerebrotendinous | 2015 |